Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 11 | 2023 | 1967 | 1.580 |
Why?
|
Brain Concussion | 7 | 2024 | 1355 | 1.390 |
Why?
|
Decompressive Craniectomy | 3 | 2022 | 76 | 1.140 |
Why?
|
Football | 3 | 2024 | 475 | 0.900 |
Why?
|
Mannitol | 2 | 2022 | 179 | 0.860 |
Why?
|
Cerebrovascular Trauma | 1 | 2022 | 22 | 0.840 |
Why?
|
Vasospasm, Intracranial | 3 | 2021 | 210 | 0.790 |
Why?
|
Coma | 2 | 2021 | 427 | 0.760 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2022 | 109 | 0.750 |
Why?
|
Hematoma, Subdural | 1 | 2021 | 126 | 0.730 |
Why?
|
Diffuse Axonal Injury | 2 | 2017 | 48 | 0.720 |
Why?
|
Diuretics, Osmotic | 1 | 2019 | 33 | 0.700 |
Why?
|
Moyamoya Disease | 2 | 2021 | 239 | 0.660 |
Why?
|
Saline Solution, Hypertonic | 1 | 2019 | 112 | 0.660 |
Why?
|
Vascular System Injuries | 1 | 2022 | 247 | 0.650 |
Why?
|
Brain Stem Hemorrhage, Traumatic | 1 | 2017 | 13 | 0.600 |
Why?
|
Tauopathies | 1 | 2021 | 313 | 0.570 |
Why?
|
Spinal Cord Injuries | 1 | 2024 | 919 | 0.530 |
Why?
|
Edema | 2 | 2020 | 770 | 0.490 |
Why?
|
Electric Injuries | 1 | 2014 | 25 | 0.490 |
Why?
|
Intracranial Hemorrhages | 4 | 2024 | 843 | 0.490 |
Why?
|
Injury Severity Score | 4 | 2023 | 1033 | 0.410 |
Why?
|
Neurology | 2 | 2018 | 762 | 0.410 |
Why?
|
Brain Stem | 1 | 2017 | 851 | 0.410 |
Why?
|
Lung Diseases | 1 | 2022 | 1899 | 0.390 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 342 | 0.370 |
Why?
|
Cerebral Hemorrhage | 2 | 2020 | 2645 | 0.360 |
Why?
|
tau Proteins | 1 | 2021 | 2053 | 0.360 |
Why?
|
Status Epilepticus | 3 | 2023 | 456 | 0.350 |
Why?
|
Encephalitis, Herpes Simplex | 2 | 2023 | 65 | 0.340 |
Why?
|
Methylprednisolone | 3 | 2024 | 384 | 0.340 |
Why?
|
Chronic Disease | 2 | 2022 | 9162 | 0.340 |
Why?
|
Withholding Treatment | 1 | 2013 | 603 | 0.330 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1822 | 0.320 |
Why?
|
Corpus Callosum | 3 | 2019 | 739 | 0.310 |
Why?
|
Brain Ischemia | 2 | 2021 | 3127 | 0.310 |
Why?
|
Stroke | 3 | 2020 | 9879 | 0.300 |
Why?
|
Critical Care | 2 | 2018 | 2677 | 0.290 |
Why?
|
Brain | 5 | 2021 | 26659 | 0.290 |
Why?
|
Heart-Assist Devices | 1 | 2018 | 1270 | 0.290 |
Why?
|
Dementia | 1 | 2021 | 2585 | 0.290 |
Why?
|
Hypertension | 2 | 2024 | 8498 | 0.260 |
Why?
|
Mental Disorders | 2 | 2022 | 6696 | 0.250 |
Why?
|
Curriculum | 1 | 2017 | 3654 | 0.220 |
Why?
|
Intensive Care Units | 3 | 2021 | 3697 | 0.210 |
Why?
|
Subarachnoid Hemorrhage | 3 | 2021 | 1025 | 0.210 |
Why?
|
Humans | 53 | 2024 | 752411 | 0.210 |
Why?
|
Anterior Temporal Lobectomy | 2 | 2023 | 45 | 0.190 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15680 | 0.190 |
Why?
|
Muscle Weakness | 2 | 2015 | 410 | 0.190 |
Why?
|
Electrolytes | 1 | 2022 | 281 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15622 | 0.190 |
Why?
|
Middle Aged | 26 | 2024 | 217039 | 0.190 |
Why?
|
Mannose-Binding Lectin | 1 | 2022 | 146 | 0.190 |
Why?
|
Prognosis | 6 | 2023 | 29337 | 0.180 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2019 | 20 | 0.170 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 139 | 0.170 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 109 | 0.170 |
Why?
|
Retrospective Studies | 13 | 2024 | 79133 | 0.160 |
Why?
|
Cerebral Revascularization | 1 | 2021 | 233 | 0.160 |
Why?
|
Inflammation | 4 | 2020 | 10696 | 0.160 |
Why?
|
Drainage | 2 | 2023 | 1153 | 0.160 |
Why?
|
Male | 33 | 2024 | 354908 | 0.160 |
Why?
|
Adult | 23 | 2024 | 216927 | 0.150 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 537 | 0.150 |
Why?
|
Hippocampus | 2 | 2021 | 3706 | 0.150 |
Why?
|
Amnesia | 1 | 2019 | 256 | 0.150 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.150 |
Why?
|
Head Injuries, Penetrating | 1 | 2016 | 27 | 0.140 |
Why?
|
Health Occupations | 1 | 2018 | 222 | 0.140 |
Why?
|
Adolescent | 10 | 2022 | 86766 | 0.140 |
Why?
|
Internship and Residency | 1 | 2017 | 5813 | 0.140 |
Why?
|
Comorbidity | 2 | 2021 | 10475 | 0.140 |
Why?
|
Necrosis | 1 | 2020 | 1601 | 0.140 |
Why?
|
Athletic Injuries | 2 | 2024 | 1179 | 0.130 |
Why?
|
Quality of Life | 3 | 2024 | 13154 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2018 | 379 | 0.130 |
Why?
|
Aged | 17 | 2024 | 166585 | 0.130 |
Why?
|
Anticoagulants | 2 | 2024 | 4831 | 0.130 |
Why?
|
Glasgow Coma Scale | 4 | 2019 | 562 | 0.130 |
Why?
|
Diffusion Tensor Imaging | 2 | 2016 | 2373 | 0.130 |
Why?
|
Female | 27 | 2024 | 386085 | 0.130 |
Why?
|
Heart Valve Prosthesis | 1 | 2024 | 1500 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9101 | 0.120 |
Why?
|
Dantrolene | 1 | 2014 | 26 | 0.120 |
Why?
|
Glasgow Outcome Scale | 1 | 2014 | 102 | 0.120 |
Why?
|
Brain Waves | 1 | 2018 | 386 | 0.120 |
Why?
|
Paresis | 1 | 2015 | 175 | 0.120 |
Why?
|
Hydrocephalus | 1 | 2021 | 756 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2020 | 1014 | 0.120 |
Why?
|
Muscle Relaxants, Central | 1 | 2014 | 90 | 0.120 |
Why?
|
Aphasia | 1 | 2015 | 190 | 0.110 |
Why?
|
Heart Failure | 1 | 2018 | 11729 | 0.110 |
Why?
|
Leukoaraiosis | 1 | 2014 | 116 | 0.110 |
Why?
|
Protein Kinases | 1 | 2020 | 1613 | 0.110 |
Why?
|
Microglia | 2 | 2018 | 1322 | 0.110 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1252 | 0.110 |
Why?
|
Olivary Nucleus | 1 | 2013 | 128 | 0.110 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2708 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1225 | 0.100 |
Why?
|
Young Adult | 9 | 2021 | 57632 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2018 | 1133 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1278 | 0.090 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1150 | 0.090 |
Why?
|
Prospective Studies | 5 | 2022 | 53809 | 0.090 |
Why?
|
Neuroprotective Agents | 2 | 2014 | 956 | 0.090 |
Why?
|
Administration, Intranasal | 2 | 2023 | 472 | 0.090 |
Why?
|
Acute Disease | 2 | 2018 | 7212 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2562 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1133 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14325 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2122 | 0.090 |
Why?
|
Ischemia | 1 | 2018 | 1875 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1417 | 0.080 |
Why?
|
Warfarin | 1 | 2018 | 1506 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1065 | 0.080 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2012 | 258 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2021 | 15438 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1624 | 0.080 |
Why?
|
Risk Factors | 5 | 2024 | 73425 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39077 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4067 | 0.070 |
Why?
|
Graft Rejection | 1 | 2020 | 4219 | 0.070 |
Why?
|
Registries | 2 | 2021 | 8367 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 17958 | 0.070 |
Why?
|
Thrombocytopenia | 1 | 2014 | 1170 | 0.070 |
Why?
|
Athletes | 2 | 2024 | 1095 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3341 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7897 | 0.060 |
Why?
|
Mice | 6 | 2023 | 80550 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12901 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 40980 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3160 | 0.060 |
Why?
|
Central Nervous System Neoplasms | 1 | 2013 | 905 | 0.060 |
Why?
|
Hospital Mortality | 2 | 2020 | 5370 | 0.060 |
Why?
|
Animals | 9 | 2023 | 166811 | 0.060 |
Why?
|
Lymphoma | 1 | 2013 | 1887 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 21157 | 0.060 |
Why?
|
Trauma Centers | 2 | 2019 | 920 | 0.050 |
Why?
|
Acyclovir | 1 | 2023 | 268 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2022 | 664 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2023 | 338 | 0.050 |
Why?
|
Water-Electrolyte Balance | 1 | 2022 | 334 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58299 | 0.050 |
Why?
|
rho-Associated Kinases | 1 | 2023 | 276 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.050 |
Why?
|
Consciousness Disorders | 1 | 2023 | 291 | 0.040 |
Why?
|
Recovery of Function | 2 | 2021 | 2921 | 0.040 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2021 | 188 | 0.040 |
Why?
|
Cerebral Veins | 1 | 2020 | 151 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2023 | 607 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2021 | 3806 | 0.040 |
Why?
|
Cell Membrane Permeability | 1 | 2020 | 575 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2023 | 948 | 0.040 |
Why?
|
Hyperkinesis | 1 | 2018 | 88 | 0.040 |
Why?
|
Age Factors | 3 | 2021 | 18298 | 0.040 |
Why?
|
Hematoma | 1 | 2022 | 768 | 0.040 |
Why?
|
Consciousness | 1 | 2022 | 452 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35932 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2018 | 249 | 0.030 |
Why?
|
Maze Learning | 1 | 2018 | 477 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1689 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2024 | 4876 | 0.030 |
Why?
|
Arousal | 1 | 2021 | 1137 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 993 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2023 | 1788 | 0.030 |
Why?
|
Models, Immunological | 1 | 2017 | 505 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 854 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2022 | 1800 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 64250 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14297 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1575 | 0.030 |
Why?
|
United States | 4 | 2024 | 71438 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1195 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2023 | 21717 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1376 | 0.030 |
Why?
|
Riluzole | 1 | 2012 | 58 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2020 | 1854 | 0.030 |
Why?
|
Anisotropy | 1 | 2016 | 1286 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2017 | 719 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2018 | 996 | 0.030 |
Why?
|
Hypertrophy | 1 | 2013 | 554 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6058 | 0.020 |
Why?
|
Occupational Therapy | 1 | 2012 | 136 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3196 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13167 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1660 | 0.020 |
Why?
|
Time Factors | 2 | 2024 | 39846 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21806 | 0.020 |
Why?
|
Seizures | 1 | 2023 | 2910 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6358 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2018 | 1177 | 0.020 |
Why?
|
Astrocytes | 1 | 2017 | 1318 | 0.020 |
Why?
|
Arm | 1 | 2012 | 582 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1563 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8420 | 0.020 |
Why?
|
Medicaid | 1 | 2022 | 2793 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 527 | 0.020 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2014 | 538 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3532 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1828 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8443 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2685 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8710 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15143 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15508 | 0.020 |
Why?
|
Education, Medical | 1 | 2018 | 1713 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 16984 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4419 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2023 | 7808 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5839 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10035 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 3029 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1793 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6686 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10196 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2012 | 1891 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3751 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10172 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3412 | 0.010 |
Why?
|
Viral Load | 1 | 2012 | 3285 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13405 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4632 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25539 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12138 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9898 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12449 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23788 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18915 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4715 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20351 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13277 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9353 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10629 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2014 | 12328 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 13897 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8511 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 41660 | 0.010 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(80)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_